BEBAC   Ing. Helmut Schütz

directly to content (skip navigation)


News

EU-EMA 2014-10-07 Q & A document
  ► read more…

EU-EMA/US-FDA 2013-12-18 Inspec­tions of BE Studies
  ► read more…

Guidances

EU-EMA 2014-11-20 Guideline on MR dosage forms
  ► read more…

EU-EMA 2014-10-23 Guideline on similar bio­lo­gical medicinal products
  ► read more…

US-FDA 2014-05-14 Draft Guidance: Clinical Pharmacology Data to Support a Demon­stra­tion of Biosimilarity to a Re­fe­rence Product
  ► read more…

US-FDA 2014-03-18 Draft Guidance: BA and BE Studies Sub­mit­ted in NDAs or INDs
  ► read more…

US-FDA 2013-12-09 Draft Guidance on Size, Shape, and Other Phy­si­cal Attri­butes of Gene­ric Tab­lets and Cap­sules
  ► read more…

US-FDA 2013-12-04 Draft Guidance on BE Studies with PK End­points for Drugs Sub­mitted Under an ANDA
  ► read more…

EU-EMA 2013-11-15 Draft product-specific guid­ances
  ► read more…

US-FDA 2013-09-13 Draft Guidance on Bio­ana­lyti­cal Method Vali­da­tion
  ► read more…

Consultancy Services for Bioequivalence and Bioavailability Studies


BEBAC specializes in providing biostatistical services, con­tractor selection and supervision. We have wide experience with bioanalytics, pharmacokinetics, and biostatistics.
Our professional expertise covers advisory activities, planning and analysis of Phase I clinical trials.
We are able to support you in planning and evaluation, responding deficiency letters, as well as preparation for regulatory hearings, placement and evaluation of CROs.


Helmut Schütz studied Chemical Engineering in Vienna and is an independent consultant in the domain of bio­availability and bioequivalence studies.
Mr Schütz has worked in the pharmaceutical industry and in an independent CRO, where he established a GLP certified laboratory information management system, holding senior mana­ge­ment positions, most recently as the head of a biostatistical department.
He has extensive experience with bioanalytics, pharma­co­kinetics, and biostatistics. His professional experience covers 34 years and more than 500 BA/BE studies.


Helmut Schütz is a member of the International Pharma­ceutical Fede­ration (FIP), the American Association of Pharma­ceutical Scientists (AAPS), the International Society for Clinical Bio­statistics (ISCB), the Inter­na­tio­nal Biometric Society (IBS), the European Net­work for Business and Industrial Sta­tis­tics (ENBIS), the Austrian Pharma­ceu­ti­cal Asso­ciation (ÖPhG), and the Austrian Association of Con­sulting Engineers (FI).

BEBAC – Consultancy Services for
Bioequivalence and Bioavailability Studies
Ing. Helmut Schütz

Neubaugasse 36/1/11
1070 Vienna, Austria
T: +43 (0)1 2311746
M: +43 (0)699 10792458
E: office@bebac.at
W: http://bebac.at/
F: http://forum.bebac.at/

document date 2011-05-13 | last update 2014-12-13

shortlived